Compare IMMR & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMR | ACB |
|---|---|---|
| Founded | 1993 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 241.4M | 232.3M |
| IPO Year | 1999 | 2016 |
| Metric | IMMR | ACB |
|---|---|---|
| Price | $6.55 | $4.15 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.81 |
| AVG Volume (30 Days) | 336.3K | ★ 1.8M |
| Earning Date | 09-14-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.47% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $35,013,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.78 |
| P/E Ratio | $39.47 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.25 | $2.56 |
| 52 Week High | $8.05 | $6.36 |
| Indicator | IMMR | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 32.06 | 38.74 |
| Support Level | $6.29 | $3.78 |
| Resistance Level | $6.83 | $4.67 |
| Average True Range (ATR) | 0.20 | 0.20 |
| MACD | -0.03 | -0.11 |
| Stochastic Oscillator | 6.58 | 0.88 |
Immersion Corp is a licensing company focused on the acceleration, and scaling, through licensing, of haptic technologies that allow people to use sense of touch to engage with products and experience the digital world around them. Its patents cover a wide range of digital technologies and ways in which touch-related technology can be incorporated into and between hardware products and components, systems software, application software, and digital content. It operates in two operating segments: Immersion and Barnes & Noble Education. The majority of revenue is derived from Barnes & Noble Education segment which is a contract operator of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.